Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Epidemiology and Infection|August 18, 2004
Prevalence and determinants of nasal colonization with antibiotic-resistant Staphylococcus aureus among unselected patients attending general practitioners in GermanyS Lietzau, T Stürmer, A Erb, et al.Infection|July 1, 1997
Life-threatening infection with multiresistant Staphylococcus epidermidis in a patient with end-stage renal disease: cure with chloramphenicol and quinupristin/dalfopristin (RP 59500)E Mündlein, H von Baum, H K Geiss, et al.Deutsche Medizinische Wochenschrift (1946)|April 7, 2011
[Epidemiology and Aetiology of Community-acquired Pneumonia (CAP)]M W Pletz, G Rohde, H Schütte, et al.Infection Control and Hospital Epidemiology|October 13, 2007
Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trialC Wendt, S Schinke, M Württemberger, et al.Emergency Medicine Journal : EMJ|February 26, 2015
Prevalence of nosocomial pathogens in German ambulances: the SEKURE studyM Wepler, W Stahl, H von Baum, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 4, 2010
Preliminary report: outbreak of Legionnaires disease in the cities of Ulm and Neu-Ulm in Germany, December 2009 - January 2010H von Baum, G Härter, A Essig, et al.The Journal of Antimicrobial Chemotherapy|February 4, 2003
Tissue and serum concentrations of levofloxacin 500 mg administered intravenously or orally for antibiotic prophylaxis in biliary surgeryS Swoboda, K Oberdorfer, F Klee, et al.Immunitat Und Infektion|February 1, 1995
[The significance of cardiolipin antibodies in systemic lupus erythematosus]S Gansauge, A Breitbart, B Brado, et al.The European Respiratory Journal|September 7, 2010
How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired PneumoniaH von Baum, B Schweiger, T Welte, et al.The European Respiratory Journal|October 26, 2007
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classesS Krüger, S Ewig, R Marre, et al.Pageof 4